MetaADEDB: ADE

MetaADEDB 2.0 @ LMMD

Fibromatosis

(UMLS:C0016048)

UMLS ID:: C0016048
MeSH ID:: D005350

Classification:

Name:

Neoplasms
MeSH Tree Number(s):: C04.557.450.565.590.340

Synonym(s)

Fibromatosis

FIBROMATOSIS

Fibromatosis, NOS

fibromatoses

fibromatosis

Associated Drug(s)

	Name	Number of Reports	Data Source
1	Alendronate	FAERS: 9	US FAERS
2	Imatinib Mesylate	FAERS: 3	US FAERS
3	Norgestrel	FAERS: 3	US FAERS
4	Pregabalin	FAERS: 3	US FAERS
5	Albuterol	FAERS: 2 Canada Vigilance: 1	Canada Vigilance US FAERS
6	Carbamazepine	FAERS: 2	US FAERS
7	NuvaRing	FAERS: 2	US FAERS
8	Sorafenib	FAERS: 2	US FAERS
9	Ciprofloxacin	FAERS: 1	US FAERS
10	Leuprolide	FAERS: 1	US FAERS
11	Medroxyprogesterone Acetate	FAERS: 1	US FAERS
12	Ofloxacin	FAERS: 1	US FAERS
13	Ortho Evra	FAERS: 1	US FAERS
14	Paclitaxel	FAERS: 1	US FAERS
15	Teriparatide	FAERS: 1	US FAERS
16	Valsartan	FAERS: 1	US FAERS
17	liposomal doxorubicin	FAERS: 1	US FAERS
18	Albuterol	Canada Vigilance: 1	Canada Vigilance
19	Leflunomide		OFFSIDES
20	Nitrofurantoin		OFFSIDES
21	Tilidine		OFFSIDES

Similar ADE(s)

	Name	Semantic Similarity
1	Fibrosarcoma	44.1%
2	Myxoma	36%
3	Neoplasms, Bone Tissue	36%
4	Chondroma	36%
5	Enchondroma	36%
6	Malignant Fibrous Histiocytoma	35.8%
7	Chondrosarcoma	35.3%
8	synovial sarcoma	35.3%
9	Clear Cell Sarcoma of Soft Tissue	35.3%
10	Dermatofibrosarcoma	31.9%
11	Dermatofibrosarcoma Protuberans	31.9%
12	Giant Cell Tumor of Bone	31.7%
13	Adenofibroma	29.4%
14	Fibroadenoma	29.4%
15	Sarcoma	28.5%
16	Osteosarcoma	27.1%
17	Osteoblastoma	23.8%
18	Osteoma	23.8%
19	Chondromatosis	23.8%
20	leukemia	22.7%
21	Neoplasms, Germ Cell and Embryonal	22.7%
22	Neoplasms, Glandular and Epithelial	22.7%
23	Germ Cell Cancer	22.7%
24	leiomyosarcoma	22.5%
25	liposarcoma	22.5%
26	Angiomyolipoma	22.5%
27	Alveolar Soft Part Sarcoma	22.5%
28	Carcinosarcoma	19.5%
29	Hemangiosarcoma	19.5%
30	lymphangiosarcoma	19.5%
31	Mastocytosis	18.7%
32	Gastrointestinal Stromal Tumors	18.4%
33	Neurofibrosarcoma	17.5%
34	Phyllodes Tumor	16.8%
35	Lipoma	16.8%
36	Myoma	16.8%
37	Angiolipoma	16.8%
38	Myelolipoma	16.8%
39	Smooth Muscle Tumor	16.8%
40	Desmoplastic Small Round Cell Tumor	16.8%
41	Neuroectodermal Tumors	16.4%
42	Mastocytoma	16.1%
43	Sarcoma, Myeloid	16%
44	Mastocytosis, Systemic	16%
45	Hamartoma	15.3%
46	Neoplasms, Hormone-Dependent	15.3%
47	Neoplasms, Multiple Primary	15.3%
48	Paraneoplastic Syndromes	15.3%
49	Precancerous Conditions	15.3%
50	Neoplasms, Second Primary	15.3%
51	Histiocytic Disorders, Malignant	15.1%
52	Rhabdomyosarcoma	14.8%
53	Neoplasms, Neuroepithelial	13.4%
54	Gliomatosis cerebri	13.4%
55	Carcinoma 256, Walker	13.1%
56	Sarcoma, Experimental	12.3%
57	Adenoma	12.2%
58	Ameloblastoma	12.2%
59	Angiokeratoma	12.2%
60	Carcinoma	12.2%
61	Chordoma	12.2%
62	Hemangioma	12.2%
63	hemangiopericytoma	12.2%
64	Lymphangioma	12.2%
65	Mesenchymoma	12.2%
66	Nevus	12.2%
67	Teratoma	12.2%
68	Hepatoblastoma	12.2%
69	Mixed Tumor, Mullerian	12.2%
70	Germinoma	12.2%
71	Teratocarcinoma	12.2%
72	Angiofibroma	12.2%
73	Epithelioma	12.2%
74	Lymphoma	11.3%
75	Rhabdomyoma	11.1%
76	Alveolar rhabdomyosarcoma	11.1%
77	melanoma	10.8%
78	Meningioma	10.4%
79	Sarcoma 180	10.2%
80	Cyst	10.2%
81	Neoplastic Processes	10.2%
82	Neoplastic Syndromes, Hereditary	10.2%
83	Pregnancy Complications, Neoplastic	10.2%
84	Trophoblastic Neoplasms	10%
85	Leukemia, Experimental	10%
86	Carcinoma, Ehrlich Tumor	9.9%
87	Dermoid Cyst	9.9%
88	Carcinoma, Lewis Lung	9.9%
89	Neoplasms, Experimental	9.9%
90	Composite Lymphoma	9.8%
91	Leukemia, Plasma Cell	9.7%
92	Lymphangioleiomyomatosis	9.6%
93	Basal cell carcinoma	9.6%
94	Carcinoma, Papillary	9.6%
95	Squamous cell carcinoma	9.6%
96	Craniopharyngioma	9.6%
97	Cystadenoma	9.6%
98	Mesothelioma	9.6%
99	Neuroectodermal Tumor, Melanotic	9.6%
100	Neuroendocrine Tumors	9.6%
101	Carcinoma, Basal Cell	9.6%
102	Endometrial Stromal Sarcoma	9.3%
103	Urticaria Pigmentosa	9.1%
104	Adenoma, Acidophil	8.4%
105	Ganglioneuroma	8.4%
106	Glioma	8.4%
107	Malignant Glioma	8.4%
108	Plasmacytoma	8.2%
109	Malignant histiocytosis	8.1%
110	Histiocytic sarcoma	8.1%
111	Leukemia, Radiation-Induced	8.1%
112	Cystadenocarcinoma	8%
113	Mucoepidermoid Carcinoma	8%
114	Leukemia L1210	7.6%
115	Leukemia P388	7.6%
116	Acanthoma	7.6%
117	Abdominal Neoplasms	7.6%
118	Erythroplasia	7.6%
119	Follicular cyst	7.6%
120	Head and Neck Neoplasms	7.6%
121	Mucocele	7.6%
122	Pilonidal Cyst	7.6%
123	Soft Tissue Neoplasms	7.6%
124	Thoracic Neoplasms	7.6%
125	Thyroglossal Cyst	7.6%
126	Synovial Cyst	7.6%
127	Aberrant Crypt Foci	7.6%
128	Neoplasms, Radiation-Induced	7.4%
129	Thymoma	7.3%
130	Melanoma, Experimental	7.3%
131	Adenocarcinoma	7.2%
132	Carcinoma in Situ	7.2%
133	Carcinoma, Transitional Cell	7.2%
134	Dysgerminoma	7.2%
135	Hemangioendothelioma	7.2%
136	Neuroma	7.2%
137	Papilloma	7.2%
138	Pseudomyxoma Peritonei	7.2%
139	Seminoma	7.2%
140	Papillomatosis	7.2%
141	Adenomatosis, Pulmonary	7.2%
142	Adenomatous Polyps	7.2%
143	Carcinoma, Large Cell	7.2%
144	Carcinoma, Small Cell	7.2%
145	Carcinoid Tumor	7.1%
146	Neurilemmoma	7.1%
147	Hutchinson's Melanotic Freckle	7.1%
148	Melanoma, Amelanotic	7.1%
149	Medulloblastoma	6.8%
150	Multiple Endocrine Neoplasia	6.6%
151	Choriocarcinoma	6.5%
152	Carcinoma, Lobular	6.5%
153	Bowen's Disease	6.3%
154	Paraganglioma	6.3%
155	Hodgkin Disease	6.1%
156	Lymphoma, Non-Hodgkin	6.1%
157	Paraneoplastic Encephalomyelitis	6%
158	Astrocytoma	5.9%
159	Ependymoma	5.9%
160	oligodendroglioma	5.9%
161	Ganglioglioma	5.9%
162	gliosarcoma	5.9%
163	Anaplastic astrocytoma	5.9%
164	Anaplastic Oligodendroglioma	5.9%
165	Mammary Neoplasms, Experimental	5.8%
166	Digestive System Neoplasms	5.4%
167	Endocrine Gland Neoplasms	5.4%
168	Eye Neoplasms	5.4%
169	Nervous System Neoplasms	5.4%
170	Malignant Carcinoid Syndrome	5.3%
171	Bone neoplasms	5.1%
172	Leukoplakia	5.1%
173	Lymphocele	5.1%
174	Pancreatic Cyst	5.1%
175	Skin Neoplasms	5.1%
176	Hematologic Neoplasms	5.1%
177	Barrett Esophagus	5%
178	Breast Cyst	5%
179	Actinic keratosis	5%
180	Mediastinal Cyst	5%
181	Neoplasm Invasiveness	5%
182	Neoplasm Metastasis	5%
183	Neoplasm Recurrence, Local	5%
184	Parovarian Cyst	5%
185	Pericardial Cyst	5%
186	Splenic Neoplasms	5%
187	Thymic Cyst	5%
188	Carcinogenesis	5%
189	Myxoid cyst	5%
190	Metastasis	5%
191	Primary amyloidosis	4.9%
192	Retinoblastoma	4.9%
193	Lymphomatoid Granulomatosis	4.9%
194	Leukemia, Myelomonocytic, Chronic	4.8%
195	Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative	4.8%
196	Adenoid Cystic Carcinoma	4.8%
197	Adenocarcinoma, Clear Cell	4.8%
198	Cholangiocarcinoma	4.8%
199	Cervical Intraepithelial Neoplasia	4.8%
200	Hemangioblastoma	4.8%
201	Lymphoma, Extranodal NK-T-Cell	4.8%
202	Pheochromocytoma	4.7%
203	Glioblastoma	4.7%
204	Neuroblastoma	4.7%
205	Glioblastoma Multiforme	4.7%
206	Nephroblastoma	4.7%
207	Tuberous Sclerosis	4.6%
208	Ganglioneuroblastoma	4.1%
209	Retroperitoneal Neoplasms	4.1%
210	Hepatocellular Adenoma	3.9%
211	Mesoblastic Nephroma	3.9%
212	Basal Cell Nevus Syndrome	3.8%
213	Sturge-Weber Syndrome	3.7%
214	Corpus Luteum Cyst	3.7%
215	Ovarian Cysts	3.7%
216	Hemangioma, Cavernous	3.6%
217	Carcinoid Heart Disease	3.6%
218	Leukemia, T-Cell	3.6%
219	Leukemia, B-Cell	3.6%
220	neurofibroma	3.6%
221	Hydatidiform Mole	3.6%
222	Lymphoma, Follicular	3.6%
223	T-Cell Lymphoma	3.6%
224	Mantle cell lymphoma	3.6%
225	Klatskin Tumor	3.6%
226	Multiple Endocrine Neoplasia Type 1	3.5%
227	Waldenstrom Macroglobulinemia	3.5%
228	Multiple Myeloma	3.5%
229	Parathyroid Neoplasms	3.4%
230	Peritoneal Neoplasms	3.4%
231	Thyroid Neoplasm	3.4%
232	Thyroid carcinoma	3.4%
233	Carcinoma, Pancreatic Ductal	3.3%
234	Liver Neoplasms, Experimental	3.3%
235	Prolactinoma	3.2%
236	Growth Hormone-Secreting Pituitary Adenoma	3.2%
237	Leukemia, Myeloid, Chronic-Phase	3.2%
238	Choledochal Cyst	3.1%
239	Acoustic Neuroma	3%
240	Peutz-Jeghers Syndrome	3%
241	Pancreatic Neoplasm	2.8%
242	Mouth Neoplasms	2.8%
243	Central Nervous System Neoplasms	2.8%
244	Vascular Neoplasms	2.8%
245	Thymus Neoplasms	2.8%
246	granulosa cell tumor	2.8%
247	Carcinoma, Ovarian Epithelial	2.8%
248	Genital Neoplasms, Female	2.7%
249	Pancreatic Pseudocyst	2.7%
250	Lymphatic Metastasis	2.7%
251	Neoplasms, Unknown Primary	2.7%
252	Leukemic Infiltration	2.7%
253	Breast Neoplasms, Male	2.7%
254	Neoplasm Micrometastasis	2.7%
255	Triple Negative Breast Neoplasms	2.7%
256	Tracheal Neoplasms	2.7%
257	Optic Nerve Glioma	2.7%
258	Adenomatous Polyposis Coli	2.7%
259	Leukoplakia, Oral	2.6%
260	Paraneoplastic Cerebellar Degeneration	2.6%
261	Vipoma	2.6%
262	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	2.4%
263	Leukemia, Large Granular Lymphocytic	2.4%
264	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	2.4%
265	Lymphoma, T-Cell, Cutaneous	2.4%
266	Lymphoma, AIDS-Related	2.4%
267	Enteropathy-Associated T-Cell Lymphoma	2.4%
268	Primary Effusion Lymphoma	2.4%
269	insulinoma	2.3%
270	Esophageal Neoplasms	2.2%
271	Limbic Encephalitis	2.2%
272	Adrenocortical carcinoma	2.1%
273	Adrenal Gland Neoplasms	2.1%
274	Gastrointestinal Neoplasms	2.1%
275	Genital Neoplasms, Male	2.1%
276	Liver neoplasms	2.1%
277	Uveal Neoplasms	2.1%
278	Nasopharyngeal carcinoma	2.1%
279	Urologic Neoplasms	2.1%
280	Sebaceous Gland Neoplasms	2.1%
281	Spinal Neoplasms	2.1%
282	Bone Marrow Neoplasms	2.1%
283	Polycystic Ovary Syndrome	2%
284	Thyroid Nodule	2%
285	Gastrinoma	1.9%
286	Glucagonoma	1.9%
287	Denys-Drash Syndrome	1.9%
288	Lambert-Eaton Myasthenic Syndrome	1.9%
289	Testicular Neoplasms	1.9%
290	Leydig Cell Tumor	1.9%
291	Renal Cell Carcinoma	1.8%
292	Papillary Renal Cell Carcinoma	1.8%
293	Mycosis Fungoides	1.8%
294	Lymphomatoid Papulosis	1.8%
295	Plasmablastic lymphoma	1.8%
296	Carcinoma, Endometrioid	1.7%
297	Xeroderma Pigmentosum	1.7%
298	Opsoclonus-Myoclonus Syndrome	1.7%
299	Meningeal Neoplasms	1.6%
300	Burkitt Lymphoma	1.6%
301	Myelitis, Transverse	1.5%
302	ovarian neoplasm	1.4%
303	Nose Neoplasms	1.3%
304	Ear Neoplasms	1.3%
305	Eyelid Neoplasms	1.3%
306	Lung Neoplasms	1.3%
307	Pleural Neoplasms	1.3%
308	Cell Transformation, Viral	1.2%
309	Brain Neoplasms	1.2%
310	Salivary Gland Neoplasms	1.2%
311	Spinal Cord Neoplasms	1.2%
312	Tongue Neoplasms	1.2%
313	Uterine Neoplasms	1.2%
314	Vaginal Neoplasms	1.2%
315	Vulvar Neoplasms	1.2%
316	Uterine Cancer	1.2%
317	Sezary Syndrome	1.2%
318	Fallopian Tube Neoplasms	1.2%
319	Palatal Neoplasms	1.2%
320	Pituitary Adenoma	1.1%
321	Pituitary Neoplasms	1.1%
322	Meningeal Carcinomatosis	1.1%
323	Zollinger-Ellison syndrome	1%
324	Pharyngeal Neoplasms	1%
325	Central Nervous System Cysts	1%
326	Bile Duct Neoplasms	1%
327	gallbladder neoplasm	1%
328	Intestinal Neoplasms	1%
329	Penile Neoplasms	1%
330	Prostatic Neoplasms	1%
331	Stomach Neoplasms	1%
332	Polycythemia Vera	1%
333	Laryngeal neoplasm	0.9%
334	Bronchial Neoplasms	0.8%
335	Bladder Neoplasm	0.8%
336	Kidney Neoplasm	0.8%
337	Ureteral Neoplasms	0.8%
338	Urethral Neoplasms	0.8%
339	Multiple Pulmonary Nodules	0.8%
340	Supratentorial Neoplasms	0.8%
341	Endometrial Neoplasms	0.8%
342	Hypopharyngeal Neoplasms	0.7%
343	Pleural Effusion, Malignant	0.7%
344	Hypopharyngeal Cancer	0.7%
345	Parotid Neoplasms	0.6%
346	Prostatic Neoplasms, Castration-Resistant	0.6%
347	Nelson Syndrome	0.6%
348	Brain Stem Neoplasms	0.6%
349	Cecal Neoplasms	0.5%
350	Duodenal Neoplasms	0.5%
351	Choroid Plexus Papilloma	0.5%
352	Tonsillar Neoplasms	0.5%
353	Cerebellar Neoplasms	0.5%
354	Nasopharyngeal Neoplasms	0.5%
355	Colorectal Neoplasms	0.5%
356	Paranasal Sinus Neoplasms	0.4%
357	Radicular Cyst	0.4%
358	Appendiceal Neoplasms	0.4%
359	Colonic Neoplasms	0.4%
360	Rectal Neoplasms	0.4%
361	Maxillary Sinus Neoplasms	0.3%
362	Anus Neoplasms	0.3%
363	Sigmoid Neoplasms	0.3%

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234